Atlas Trials

EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

Clinical trial NCT02689518 · COMPLETED

Trial details

NCT number
NCT02689518
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Macular DegenerationWet Macular Degeneration
Start date
2014-04-01
Primary completion
2019-11-12
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.